MarketScreener Editorial Features Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
Equities
1349
CNE1000000W4
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 HKD | +0.56% |
|
-1.10% | -29.80% |
21/06 | Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Patient for Glioma Drug Trial | MT |
21/06 | Shanghai Fudan Zhangjiang Bio-Pharmaceutical Terminates Libod Marketing Agreement | MT |
- Stock Market
- Equities
- 1349 Stock
- News Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
- MarketScreener Editorial Features